tetradecanoylphorbol acetate has been researched along with juglone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Kuramochi, K; Kuriyama, I; Maruo, S; Mizushina, Y; Tsubaki, K; Yoshida, H | 1 |
| Chae, JI; Cho, JH; Cho, MK; Kim, DJ; Lee, KA; Lee, SH; Nam, HS; Shim, JH; Woo, KM | 1 |
| Ahmad, T; Roberts, R; Shah, AJ | 1 |
3 other study(ies) available for tetradecanoylphorbol acetate and juglone
| Article | Year |
|---|---|
Inhibitory effect of novel 5-O-acyl juglones on mammalian DNA polymerase activity, cancer cell growth and inflammatory response.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Cell Line, Tumor; DNA Polymerase beta; Enzyme Inhibitors; Humans; Inflammation; Lipopolysaccharides; Mice; Naphthoquinones; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha | 2011 |
Phosphoinositol 3-kinase, a novel target molecule for the inhibitory effects of juglone on TPA-induced cell transformation.
Topics: Androstadienes; Animals; Cell Line; Cell Transformation, Neoplastic; Chromones; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Endothelial Growth Factors; Extracellular Signal-Regulated MAP Kinases; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Mice; Morpholines; Naphthoquinones; Phosphatidylinositol 3-Kinase; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-fos; Ribosomal Protein S6 Kinases, 90-kDa; Skin; Tetradecanoylphorbol Acetate; Transcription Factor AP-1; Wortmannin | 2012 |
Mechanisms mediating the vasodilatory effects of juglone in porcine isolated coronary artery.
Topics: Animals; Calcium; Coronary Vessels; Cyclic GMP; Indoles; Ionomycin; Naphthoquinones; Nitric Oxide; Potassium Channel Blockers; Swine; Tetradecanoylphorbol Acetate; Vasoconstriction; Vasodilation; Vasodilator Agents | 2020 |